Abacus backs Mountaingate’s acquisition of BioDerm

Abacus Finance Group LLC has provided $26.3 million in credit facilities to back Mountaingate Capital's buyout of BioDerm.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this